Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; email:
Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Annu Rev Virol. 2022 Sep 29;9(1):329-351. doi: 10.1146/annurev-virology-100220-113942. Epub 2022 Jun 7.
Herpesviruses are ancient large DNA viruses that have exploited gene capture as part of their strategy to escape immune surveillance, promote virus spreading, or reprogram host cells to benefit their survival. Most acquired genes are transmembrane proteins and cytokines, such as viral G protein-coupled receptors (vGPCRs), chemokines, and chemokine-binding proteins. This review focuses on the vGPCRs encoded by the human β- and γ-herpesviruses. These include receptors from human cytomegalovirus, which encodes four vGPCRs: US27, US28, UL33, and UL78; human herpesvirus 6 and 7 with two receptors: U12 and U51; Epstein-Barr virus with one: BILF1; and Kaposi's sarcoma-associated herpesvirus with one: open reading frame 74, ORF74. We discuss ligand binding, signaling, and structures of the vGPCRs in light of robust differences from endogenous receptors. Finally, we briefly discuss the therapeutic targeting of vGPCRs as future treatment of acute and chronic herpesvirus infections.
疱疹病毒是古老的大型 DNA 病毒,它们利用基因捕获作为其逃避免疫监视、促进病毒传播或重编程宿主细胞以利于其生存的策略的一部分。大多数获得的基因是跨膜蛋白和细胞因子,如病毒 G 蛋白偶联受体(vGPCR)、趋化因子和趋化因子结合蛋白。本综述重点介绍了人类β-和γ-疱疹病毒编码的 vGPCR。这些包括人巨细胞病毒编码的四个 vGPCR:US27、US28、UL33 和 UL78;人类疱疹病毒 6 和 7 有两个受体:U12 和 U51;Epstein-Barr 病毒有一个:BILF1;卡波济肉瘤相关疱疹病毒有一个:开放阅读框 74,ORF74。我们根据与内源性受体的显著差异,讨论了 vGPCR 的配体结合、信号转导和结构。最后,我们简要讨论了 vGPCR 的治疗靶向作为治疗急性和慢性疱疹病毒感染的未来治疗方法。